Jonathan H. LeBowitz
Geen lopende functies
Profiel
Dr. Jonathan H.
LeBowitz is Chief Scientific Officer & EVP at ZyStor Therapeutics, Inc. and an Advisor at Venture Investors LLC.
Prior to Venture Investors LLC, Dr. LeBowitz was an Associate Professor of Biochemistry at Purdue University.
Dr. LeBowitz received several PhDs from Harvard University, the Massachusetts Institute of Technology and Johns Hopkins University.
Eerdere bekende functies van Jonathan H. LeBowitz
| Bedrijven | Functie | Einde |
|---|---|---|
| Purdue University | Corporate Officer/Principal | - |
ZyStor Therapeutics, Inc.
 ZyStor Therapeutics, Inc. Medical SpecialtiesHealth Technology ZyStor Therapeutics, Inc. develops innovative therapeutics. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was founded by Brian L. Clevinger, James S. Manuso and Allan R. Goldberg and is headquartered in Milwaukee, WI. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jonathan H. LeBowitz
| Harvard University | Doctorate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| The Johns Hopkins University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
ZyStor Therapeutics, Inc.
ZyStor Therapeutics, Inc. Medical SpecialtiesHealth Technology ZyStor Therapeutics, Inc. develops innovative therapeutics. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was founded by Brian L. Clevinger, James S. Manuso and Allan R. Goldberg and is headquartered in Milwaukee, WI. | Health Technology |
